---
title: "DUTIA SUREN G — Ownership Dossier"
canonical: https://whiteintel.dev/entity/feeb653e-257c-5655-b579-4b3eee7fb7ae
json: https://whiteintel.dev/api/public/dossier/feeb653e-257c-5655-b579-4b3eee7fb7ae
identifier: sec:0001514063
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# DUTIA SUREN G

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001514063`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/feeb653e-257c-5655-b579-4b3eee7fb7ae  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/feeb653e-257c-5655-b579-4b3eee7fb7ae  

## Ownership & control

### Holdings / subsidiaries

- **CITIUS ONCOLOGY, INC.** (director) — https://whiteintel.dev/entity/8bd73e19-aa63-5bf1-8ea6-e1fb74b0127c
- **CITIUS PHARMACEUTICALS, INC.** (director) — https://whiteintel.dev/entity/c89aa899-7102-529d-887d-bf8510fbfb41
- **ACCEL BRANDS, INC.** (director) — https://whiteintel.dev/entity/4170cd33-2716-576f-b2fb-15407eaa17cd

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **DUTIA SUREN G**. Human view: https://whiteintel.dev/entity/feeb653e-257c-5655-b579-4b3eee7fb7ae · Structured JSON: https://whiteintel.dev/api/public/dossier/feeb653e-257c-5655-b579-4b3eee7fb7ae._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._